The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




AstraZeneca PLC - AZN QTERN (saxa/dapa) EU approved for type-2 diabetes
14:15 19-Jul-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN TAGRISSO MET PRIMARY ENDPOINT IN PHASE III TRIAL
07:00 18-Jul-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Second Price Monitoring Extn
12:07 14-Jul-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Price Monitoring Extension
12:02 14-Jul-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AZ resolves Faslodex patent litigation in the US
07:00 13-Jul-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AZ enters licensing agreements with LEO Pharma
07:00 01-Jul-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Zavicefta approved in EU
07:00 28-Jun-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AstraZeneca updates on Flumist vaccine in the US
07:00 23-Jun-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AZ agreement with Aspen for anaesthetics portfolio
07:03 09-Jun-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AZ completes US licensing agreement with Ironwood
07:00 03-Jun-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AZ LICENSES ZURAMPIC TO GRÜNENTHAL GMBH
07:00 02-Jun-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA
12:36 27-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Positive results from AstraZeneca Faslodex trial
07:03 27-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN AstraZeneca receives CRL from US FDA for ZS-9
07:00 27-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN TOP-LINE RESULTS FROM LYNPARZA GOLD TRIAL
07:00 18-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN POSITIVE BENRALIZUMAB RESULTS IN SEVERE ASTHMA
07:00 17-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US
07:00 12-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Publication of Final Terms
17:30 11-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Launch and pricing of EUR2.2bn bond issues
17:35 09-May-2016  RNS  0.89% View chart
AstraZeneca PLC - AZN Publication of a Prospectus
15:00 05-May-2016  RNS  0.89% View chart

 Page 1 of 2

| 1 | 2 | Next



RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



rssRNS feeds
Allows you to be kept updated with RNS announcements.


The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds